Vast majority of research on FOXM1 consistently highlights its high expression correlating with radio and chemoresistance, which may lead to unfavorable patient outcomes in various cancers such as breast cancer [29], small cell lung cancer [30]. Here, FOXM1 is linked to small cell lung carcinoma.